Patents by Inventor Collin Powers

Collin Powers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CMV GLYCOPROTEINS AND RECOMBINANT VECTORS
    Publication number: 20170350887
    Abstract: This invention also relates to recombinant vectors expressing one or more of the human CMV (HCMV) glycoproteins US2, US3, US6 and US11 or corresponding functional rhesus CMV (RhCMV) homologues Rh182, Rh184, Rh185 or Rh189, methods of making them, uses for them, expression products from them, and uses for the expression products. This invention also relates to recombinant cytomegalovirus vectors vectors lacking one or more of the glycoproteins, methods of making them, uses for them, expression products from them, and uses for the expression products.
    Type: Application
    Filed: December 9, 2016
    Publication date: December 7, 2017
    Inventors: Louis Picker, Klaus Frueh, Scott G. Hansen, Collin Powers
  • CMV glycoproteins and recombinant vectors
    Patent number: 9541553
    Abstract: This invention also relates to recombinant vectors expressing one or more of the human CMV (HCMV) glycoproteins US2, US3, US6 and US11 or corresponding functional rhesus CMV (RhCMV) homologues Rh182, Rh184, Rh185 or Rh189, methods of making them, uses for them, expression products from them, and uses for the expression products. This invention also relates to recombinant cytomegalovirus vectors vectors lacking one or more of the glycoproteins, methods of making them, uses for them, expression products from them, and uses for the expression products.
    Type: Grant
    Filed: February 12, 2014
    Date of Patent: January 10, 2017
    Assignee: Oregon Health & Science University
    Inventors: Louis Picker, Klaus Frueh, Scott G. Hansen, Collin Powers
  • CMV GLYCOPROTEINS AND RECOMBINANT VECTORS
    Publication number: 20140302530
    Abstract: This invention also relates to recombinant vectors expressing one or more of the human CMV (HCMV) glycoproteins US2, US3, US6 and US11 or corresponding functional rhesus CMV (RhCMV) homologues Rh182, Rh184, Rh185 or Rh189, methods of making them, uses for them, expression products from them, and uses for the expression products. This invention also relates to recombinant cytomegalovirus vectors vectors lacking one or more of the glycoproteins, methods of making them, uses for them, expression products from them, and uses for the expression products.
    Type: Application
    Filed: February 12, 2014
    Publication date: October 9, 2014
    Applicant: OREGON HEALTH AND SCIENCE UNIVERSITY
    Inventors: Louis Picker, Klaus Frueh, Scott G. Hansen, Collin Powers